CLINICAL_TRIALS
trial_result
· 2023-12-12
Clinical Trial Update: Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/ [Phase 2]
Summary
Phase 2a trial evaluating PLN-74809 on αvβ6 receptor occupancy in idiopathic pulmonary fibrosis; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pliant Therapeutics, Inc. | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2023-12-12